A Phase 1, 2-Arm, Open-Label, Parallel, Multiple-Dose Study to Assess the Pharmacokinetics of Two Rifaximin Formulations in Adult Subjects with Impaired Hepatic Function and Healthy Matched Control Adult Subjects with Normal Hepatic Function

Principal Investigator

Richard Preston

Enrollment Status

Closed

Clinical Trial ID

Institutional Protocol # 20191001

Clinical Trial Summary

Protocol RNPK1008
A Phase 1, 2-Arm, Open-Label, Parallel, Multiple-Dose Study to Assess the Pharmacokinetics of Two Rifaximin Formulations in Adult Subjects with Impaired Hepatic Function and Healthy Matched Control Adult Subjects with Normal Hepatic Function

Phase

Phase I

Funding Agency/Sponsor

Industry

Disease

Other

Contact Information

Study Contact Olga Acosta

Phone Number +1 (305) 9844319

Email oacosta@miami.edu